R&D Systems™ Recombinant Human TGF-beta 3 (CHO-expressed) Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human TGF-beta 3 (CHO-expressed) Protein is derived from CHO. The Recombinant Human TGF-beta 3 (CHO-expressed) Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P10600
• Formulation: Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA
• Gene ID (Entrez): 7043
• Molecular Weight (g/mol): 13kDa
• Name: TGF-beta 3
• Preparation Method: Reconstitute at 50μg/mL in 4mM HCl.
• Quality Control Testing: SDS-PAGE: 9-11kDa, reducing conditions
• Quantity: 25 μg
• Source: Chinese Hamster Ovary cell line,CHO-derived human TGF-beta 3 protein Ala301-Ser412
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Termination: Ala301
• Without Additives: Carrier Protein
• Structural Form: Disulfide-linked homodimer
• Gene Alias: ARVD, ARVD1, FLJ16571, LDS5, RNHF, TGFB3, TGFbeta 3, TGF-beta3, TGF-beta-3, transforming growth factor beta-3, transforming growth factor, beta 3
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.